ClinicalTrials.Veeva

Menu

Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) Shocks

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

ICD SHOCKS
DRONEDARONE
ICD

Treatments

Drug: Dronedarone
Drug: Dronedarone arm

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Recurrent ICD shocks are a serious problem in pts with ICD. Treatment failure with other antiarrhythmics and ablation are common. Dronedarone is a new antiarrhythmic drug with ion channel properties similar to amiodarone.

Several case reports have shown promising results with Dronedarone for this patient population.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Recurernt ICD shocks depite other antiarrhythmic drug therapy

Exclusion criteria

  • CHF NYHA IV OR DECMPENSATED III
  • PERMANENT AF
  • LIVER DYSFUNCION
  • CR CLEARANCE <30

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Dronedrone Arm
Other group
Treatment:
Drug: Dronedarone
Drug: Dronedarone arm

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems